0001104659-21-124836.txt : 20211008
0001104659-21-124836.hdr.sgml : 20211008
20211008215757
ACCESSION NUMBER: 0001104659-21-124836
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211006
FILED AS OF DATE: 20211008
DATE AS OF CHANGE: 20211008
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Geffon Steven
CENTRAL INDEX KEY: 0001886764
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39727
FILM NUMBER: 211316523
MAIL ADDRESS:
STREET 1: C/O LIFESCI ACQUISITION II CORP.
STREET 2: 250 W 55TH STREET, #3401
CITY: NEW YORK
STATE: NY
ZIP: 10019
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Science 37 Holdings, Inc.
CENTRAL INDEX KEY: 0001819113
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 844278203
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 600 CORPORATE POINTE
STREET 2: SUITE 320
CITY: CULVER CITY
STATE: CA
ZIP: 90230
BUSINESS PHONE: (984)377-3737
MAIL ADDRESS:
STREET 1: 600 CORPORATE POINTE
STREET 2: SUITE 320
CITY: CULVER CITY
STATE: CA
ZIP: 90230
FORMER COMPANY:
FORMER CONFORMED NAME: Lifesci Acquisition II Corp.
DATE OF NAME CHANGE: 20200723
4
1
tm2129593d17_4.xml
OWNERSHIP DOCUMENT
X0306
4
2021-10-06
0
0001819113
Science 37 Holdings, Inc.
SNCE
0001886764
Geffon Steven
C/O 3411 SILVERSIDE RD, TATNALL BUILDING
#104
WILMINGTON
DE
19810
0
1
0
0
Chief Commercial Officer
Stock Option
0.28
2021-10-06
4
A
0
914916
A
2030-04-21
Common Stock
914916
914916
D
Pursuant to the business combination of LifeSci Acquisition II Corp and Science 37, Inc. ("Old Science 37"), as contemplated by that certain agreement and plan of merger, dated May 6, 2021 (the "Merger Agreement"), (a) each share of common stock of Old Science 37 outstanding immediately prior to the effective time of the business combination was converted into approximately 1.8153 shares of the Issuer's Common Stock, (b) (the "Conversion Ratio"); and (b) each outstanding stock option of Old Science 37 was converted into a corresponding option to purchase shares of the Issuer's Common Stock as adjusted for the Conversion Ratio
Represents an option vesting with respect to 25% of the shares subject to the option on the first anniversary of the vesting start date, December 9, 2019, and with respect to 1/48th of the shares subject to the option on each monthly anniversary of the applicable vesting start date thereafter, subject to the applicable executive's continued service through the applicable vesting date.
/s/ Christine Pellizzari, Attorney-in-Fact for Steven Geffon
2021-10-08